Biofrontera (BFRI) Operating Income (2020 - 2025)
Historic Operating Income for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to -$6.3 million.
- Biofrontera's Operating Income fell 2657.26% to -$6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year increase of 902.24%. This contributed to the annual value of -$17.2 million for FY2024, which is 2410.81% up from last year.
- Latest data reveals that Biofrontera reported Operating Income of -$6.3 million as of Q3 2025, which was down 2657.26% from -$5.1 million recorded in Q2 2025.
- Biofrontera's Operating Income's 5-year high stood at -$1.7 million during Q4 2024, with a 5-year trough of -$16.1 million in Q3 2021.
- Moreover, its 5-year median value for Operating Income was -$5.0 million (2024), whereas its average is -$5.2 million.
- Its Operating Income has fluctuated over the past 5 years, first plummeted by 58707.34% in 2021, then skyrocketed by 7740.45% in 2022.
- Quarter analysis of 5 years shows Biofrontera's Operating Income stood at -$1.9 million in 2021, then crashed by 196.86% to -$5.6 million in 2022, then skyrocketed by 30.75% to -$3.9 million in 2023, then soared by 55.71% to -$1.7 million in 2024, then plummeted by 266.71% to -$6.3 million in 2025.
- Its Operating Income was -$6.3 million in Q3 2025, compared to -$5.1 million in Q2 2025 and -$4.5 million in Q1 2025.